scholarly journals Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan

2020 ◽  
Author(s):  
Ryoichi Ishibashi ◽  
Yusuke Baba ◽  
Kyoka Kakinuma ◽  
Atsushi Takasaki ◽  
Chihiro Hiraga ◽  
...  
2000 ◽  
Vol 11 (5) ◽  
pp. 455-459 ◽  
Author(s):  
M. M. Campos Pastor ◽  
P. J. López-Ibarra ◽  
F. Escobar-Jiménez ◽  
M. D. Serrano Pardo ◽  
A. García-Cervigón

1994 ◽  
Vol 23 (2) ◽  
pp. 95-102 ◽  
Author(s):  
Alicia Schiffrin ◽  
Antonio Ciampi ◽  
Lisa Hendricks ◽  
Rima Rozen ◽  
Gabriel Weitzner

2014 ◽  
Vol 6 (1) ◽  
Author(s):  
Bogdan Timar ◽  
Romulus Timar ◽  
Alin Albai ◽  
Dana Stoian ◽  
Razvan Nitu ◽  
...  

2004 ◽  
Vol 22 (15) ◽  
pp. 1015-1027 ◽  
Author(s):  
Frederick B Dong ◽  
Stephen W Sorensen ◽  
Diane L Manninen ◽  
Theodore J Thompson ◽  
Venkat Narayan ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Marcin Braun ◽  
Bartlomiej Tomasik ◽  
Ewa Wrona ◽  
Wojciech Fendler ◽  
Przemyslawa Jarosz-Chobot ◽  
...  

Introduction. It remains unclear howHbA1crecommendations influence metabolic control of paediatric patients with type 1 diabetes mellitus. To evaluate this we compared reportedHbA1cwith guideline thresholds.Materials and Methods. We searched systematically MEDLINE and EMBASE for studies reporting onHbA1cin children with T1DM and grouped them according to targetedHbA1cobtained from regional guidelines. We assessed the discrepancies in the metabolic control between these groups by comparing meanHbA1cextracted from each study and the differences between actual and targetedHbA1c.Results. We included 105 from 1365 searched studies. The median (IQR)HbA1cfor the study population was 8.30% (8.00%–8.70%) and was lower in “6.5%” than in “7.5%” as targetedHbA1clevel (8.20% (7.85%–8.57%) versus 8.40% (8.20%–8.80%);p=0.028). Median difference between actual and targetedHbA1cwas 1.20% (0.80%–1.70%) and was higher in “6.5%” than in “7.5%” (1.70% (1.30%–2.07%) versus 0.90% (0.70%–1.30%), resp.;p<0.001).Conclusions. Our study indicates that the 7.5% threshold results inHbA1clevels being closer to the therapeutic goal, but the actual values are still higher than those observed in the “6.5%” group. A meta-analysis of raw data from national registries or a prospective study comparing both approaches is warranted as the next step to examine this subject further.


Sign in / Sign up

Export Citation Format

Share Document